Prot #BAY 59-7939/17454: An International, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial Investigating the Efficacy and Safety of Rivaroxaban to Reduce the Risk of Major Thrombotic Vascular Events in Patients with Symptomatic P